1,25-Dihydroxyvitamin D3 Alleviates Salivary Adenoid Cystic Carcinoma Progression By Suppressing Gpx1 Expression Through The Nf-Kappa B Pathway

Zhiquan Huang,Yeqing Liu,Zixian Huang,Haifeng Li,Xiangfeng Gan,Zhuojian Shen
DOI: https://doi.org/10.3892/ijo.2016.3341
2016-01-01
International Journal of Oncology
Abstract:1,25-Dihydroxyvitamin D3 (1,25D3) is the active form of vitamin D with antineoplastic effects. The glutathione peroxidase-1 (GPX1) gene is associated with tumour progression. The present study aimed to explore the role of GPX1 in 1,25D3-mediated progression of salivary adenoid cystic carcinoma (SACC). Downregulating GPX1 expression inhibited SACC cell proliferation, chemoresistance, motility, and uPA secretion, but promoted apoptosis via the NF-kappa B pathway. Pre-processing 1,25D3 inhibited expression of NF-kappa B/GPX1/uPA, which subsequently suppressed cell motility and cisplatin-resistance in ACC-2 cells. In conclusion, 1,25D3 works as a modifier of NF-kappa B/GPX1/uPA expression, inhibiting cisplatin-resistance and cell invasive ability of SACC cells. The present study comprehensively elucidated the potential mechanism underlying the effects of vitamin D on chemoresistance and invasive potential in SACC.
What problem does this paper attempt to address?